Hyaluronan Contributes to Bronchiolitis Obliterans Syndrome and Stimulates Lung Allograft Rejection through Activation of Innate Immunity
Evidence level: clinical sample analysis with mouse lung transplant experiments; abstract-only
Hyaluronan was raised in recipients with BOS, and in mice it stimulated lung allograft rejection through innate immune signalling.
As of . Primary source: Publisher record via DOI.
Summary
The study measured hyaluronan (HA), a component of the tissue matrix, in lavage and plasma samples from lung recipients with or without established BOS. According to the abstract, HA was found within areas of small-airway fibrosis in BOS lung tissue, transcripts for HA-making enzymes were higher in BOS tissue, and lavage and plasma HA concentrations were higher in recipients with BOS. In mouse lung transplant recipients with established tolerance, low-molecular-weight HA broke tolerance through TLR2/4 and MyD88 signalling and expanded alloantigen-specific T cells, and neutrophil recruitment promoted rejection, while high-molecular-weight HA reduced baseline inflammation. The authors suggest HA accumulation could contribute to BOS by activating innate immune pathways. The numbers of patients are not stated in the abstract.
Details
- doi
- 10.1164/rccm.201308-1481oc
- pmid
- 24471427
- authors
- Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, Pavlisko EN, Kelly FL, Huang H, Kreisel D, Palmer SM, Gelman AE
- journal
- American Journal of Respiratory and Critical Care Medicine
- year
- 2014
- volume
- 189
- issue
- 5
- pages
- 556-566
Sources and links
- Publisher record via DOI (primary)
- PubMed 24471427
Related
Links from this record
- supports: Innate immune activation
- discusses: Bronchiolitis obliterans syndrome (BOS)
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- author affiliations
- centre or centres not stated in the abstract
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.